DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea
· Delayed Price · Currency is KRW 14,800
-50 (-0.34%)
At close: Aug 14, 2025, 3:30 PM KST
DAE HWA Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 148,545 | 149,409 | 141,359 | 131,912 | 117,159 | 109,346 | Upgrade
|
| Other Revenue | -0 | - | -0 | - | - | - | Upgrade
|
| Revenue | 148,545 | 149,409 | 141,359 | 131,912 | 117,159 | 109,346 | Upgrade
|
| Revenue Growth (YoY) | 0.82% | 5.70% | 7.16% | 12.59% | 7.14% | -4.59% | Upgrade
|
| Cost of Revenue | 97,029 | 97,197 | 96,698 | 86,298 | 73,907 | 66,973 | Upgrade
|
| Gross Profit | 51,516 | 52,212 | 44,661 | 45,614 | 43,252 | 42,372 | Upgrade
|
| Selling, General & Admin | 37,913 | 36,677 | 34,309 | 32,496 | 31,345 | 32,210 | Upgrade
|
| Research & Development | 5,982 | 7,241 | 5,984 | 5,374 | 6,641 | 5,620 | Upgrade
|
| Other Operating Expenses | 344.31 | 348.08 | 347.44 | 352.59 | 308.25 | 411.79 | Upgrade
|
| Operating Expenses | 44,994 | 45,500 | 42,699 | 39,767 | 39,968 | 38,430 | Upgrade
|
| Operating Income | 6,522 | 6,712 | 1,962 | 5,847 | 3,284 | 3,942 | Upgrade
|
| Interest Expense | -5,140 | -5,458 | -4,674 | -2,365 | -1,519 | -5,406 | Upgrade
|
| Interest & Investment Income | 46.66 | 30.35 | 341.26 | 348.19 | 427.24 | 396.69 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -212.81 | -206.86 | Upgrade
|
| Currency Exchange Gain (Loss) | -82.9 | -158.7 | 44.83 | -15.35 | 104.33 | -65.56 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,266 | 1,091 | 1,661 | 2,253 | 4,019 | 524.3 | Upgrade
|
| EBT Excluding Unusual Items | 2,611 | 2,217 | -664.3 | 6,067 | 6,103 | -815.37 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -1,431 | -966.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | -459.1 | -366.55 | 381.4 | -766.9 | 362.47 | 992.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -18.07 | -1.21 | -1.07 | -6.6 | Upgrade
|
| Asset Writedown | -337 | -337 | -155 | -2,873 | -1,182 | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.05 | 673.21 | - | Upgrade
|
| Pretax Income | 1,815 | 1,513 | -455.97 | 2,426 | 4,525 | -795.98 | Upgrade
|
| Income Tax Expense | 1,035 | 683.33 | 58.35 | 1,205 | 2,562 | 1,687 | Upgrade
|
| Earnings From Continuing Operations | 779.43 | 829.84 | -514.32 | 1,221 | 1,962 | -2,483 | Upgrade
|
| Minority Interest in Earnings | -127.17 | -298.42 | -632.48 | -105.5 | 254.96 | 475.38 | Upgrade
|
| Net Income | 652.26 | 531.42 | -1,147 | 1,116 | 2,217 | -2,008 | Upgrade
|
| Net Income to Common | 652.26 | 531.42 | -1,147 | 1,116 | 2,217 | -2,008 | Upgrade
|
| Net Income Growth | - | - | - | -49.69% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 17 | 18 | 18 | 17 | 17 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 18 | 18 | 17 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | -1.85% | -0.72% | 1.21% | -0.16% | 0.87% | -1.48% | Upgrade
|
| EPS (Basic) | 37.49 | 30.34 | -65.00 | 64.00 | 127.00 | -116.00 | Upgrade
|
| EPS (Diluted) | 37.49 | 30.34 | -65.00 | 64.00 | 127.00 | -116.00 | Upgrade
|
| EPS Growth | - | - | - | -49.61% | - | - | Upgrade
|
| Free Cash Flow | 5,768 | 875.3 | -9,122 | -19,497 | 701.81 | -1,114 | Upgrade
|
| Free Cash Flow Per Share | 331.53 | 49.97 | -517.02 | -1118.47 | 40.20 | -64.36 | Upgrade
|
| Gross Margin | 34.68% | 34.95% | 31.59% | 34.58% | 36.92% | 38.75% | Upgrade
|
| Operating Margin | 4.39% | 4.49% | 1.39% | 4.43% | 2.80% | 3.60% | Upgrade
|
| Profit Margin | 0.44% | 0.36% | -0.81% | 0.85% | 1.89% | -1.84% | Upgrade
|
| Free Cash Flow Margin | 3.88% | 0.59% | -6.45% | -14.78% | 0.60% | -1.02% | Upgrade
|
| EBITDA | 12,810 | 13,117 | 7,833 | 10,388 | 8,102 | 9,610 | Upgrade
|
| EBITDA Margin | 8.62% | 8.78% | 5.54% | 7.88% | 6.92% | 8.79% | Upgrade
|
| D&A For EBITDA | 6,289 | 6,405 | 5,871 | 4,541 | 4,818 | 5,668 | Upgrade
|
| EBIT | 6,522 | 6,712 | 1,962 | 5,847 | 3,284 | 3,942 | Upgrade
|
| EBIT Margin | 4.39% | 4.49% | 1.39% | 4.43% | 2.80% | 3.60% | Upgrade
|
| Effective Tax Rate | 57.05% | 45.16% | - | 49.67% | 56.63% | - | Upgrade
|
| Advertising Expenses | - | 1,696 | 3,127 | 3,256 | 3,598 | 4,013 | Upgrade
|
Updated May 14, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.